Contact Us

GLG Pharma is an oncology company focused on the development of diagnostics and drugs that target the STAT3 protein molecule, causing it to rapidly degrade. Cancer cells are addicted to high levels of STAT3 protein and when it degrades, the cancer cells become vulnerable to chemotherapy, biotherapeutics, vaccines, and radiation therapies.

If you and your team are interested in licensing technology for combination therapies then contact us by filling out the form.

If you are interested in learning how to have a better laboratory outcome of cancer cell screening then visit our products page.